Rezo Therapeutics utilizes its Sequence to Systems to Drugs (SSD) platform, which integrates proteomics, genetics, structural biology, and bioinformatics, to create detailed maps of molecular disease networks. This approach enables oncologists and researchers to identify novel therapeutic targets with greater precision than traditional drug discovery methods, addressing the complexity of disease biology.
Funding
$78M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional drug discovery methods often struggle to address the complexity of disease biology, leading to imprecise therapeutic targets and limited efficacy, especially in oncology. The abundance of genomic data presents challenges in translating sequence to function, hindering the development of effective treatments.
Solution
Rezo Therapeutics employs its Sequence to Systems to Drugs (SSD) platform to construct comprehensive maps of molecular disease networks by integrating proteomics, genetics, structural biology, and bioinformatics data. This systems-level approach enables the identification of novel therapeutic targets with greater precision compared to conventional methods. By leveraging multi-omic data, Rezo aims to overcome the limitations of sequence-based drug discovery and develop more effective precision therapeutics. The platform facilitates a deeper understanding of disease mechanisms, leading to the design of targeted interventions.
Target Audience
The primary audience includes oncologists and researchers focused on identifying and validating novel therapeutic targets for cancer treatment.
Features
- Multi-omic data integration: Combines proteomics, genetics, structural biology, and bioinformatics.
- Sequence to Systems to Drugs (SSD) platform: Creates detailed maps of molecular disease networks.
- Identification of novel therapeutic targets: Enables precise targeting of disease mechanisms.
- Advanced technology approach: Provides a more complete and accurate view of mechanisms that cause disease.